- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Oncogenic Mutant p53 for Cancer Therapy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-12-21
DOI
10.3389/fonc.2015.00288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of pesticide chemicals on the activity of metabolic enzymes: focus on thiocarbamates
- (2018) Cécile Mathieu et al. Expert Opinion on Drug Metabolism & Toxicology
- A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)
- (2015) S. Ramalingam et al. ANNALS OF ONCOLOGY
- Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
- (2015) Shengliang Zhang et al. CANCER RESEARCH
- Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis
- (2015) Masatsugu Hiraki et al. CHEMISTRY & BIOLOGY
- Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
- (2015) Lee M Krug et al. LANCET ONCOLOGY
- Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
- (2015) E. M. Alexandrova et al. NATURE
- A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
- (2015) H. Nechushtan et al. ONCOLOGIST
- p53 orchestrates between normal differentiation and cancer
- (2015) Noa Rivlin et al. SEMINARS IN CANCER BIOLOGY
- Targeting Mutant p53 by a SIRT1 Activator YK-3-237 Inhibits the Proliferation of Triple-Negative Breast Cancer Cells
- (2015) Yong Weon Yi et al. Oncotarget
- Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism
- (2015) Xin Yu et al. Oncotarget
- Chemopreventive Effects of the p53-Modulating Agents CP-31398 and Prima-1 in Tobacco Carcinogen-Induced Lung Tumorigenesis in A/J Mice
- (2015) Chinthalapally V. Rao et al. NEOPLASIA
- Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
- (2014) M N Saha et al. BRITISH JOURNAL OF CANCER
- Identification and Characterization of Small Molecules That Inhibit Nonsense-Mediated RNA Decay and Suppress Nonsense p53 Mutations
- (2014) L. Martin et al. CANCER RESEARCH
- p53 as a target for the treatment of cancer
- (2014) Michael J. Duffy et al. CANCER TREATMENT REVIEWS
- A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer
- (2014) Komal Jhaveri et al. Clinical Breast Cancer
- Mutant p53 reactivation by small molecules makes its way to the clinic
- (2014) Vladimir J.N. Bykov et al. FEBS LETTERS
- Limiting the power of p53 through the ubiquitin proteasome pathway
- (2014) Vinod Pant et al. GENES & DEVELOPMENT
- Molecular Analysis, Pathogenic Mechanisms, and Readthrough Therapy on a Large Cohort of Kabuki Syndrome Patients
- (2014) Lucia Micale et al. HUMAN MUTATION
- A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinoma
- (2014) Lipika Goyal et al. INVESTIGATIONAL NEW DRUGS
- Randomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life Outcomes
- (2014) Fabio Efficace et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression
- (2014) Noemi Reguart et al. LUNG CANCER
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- The cellular thermal shift assay for evaluating drug target interactions in cells
- (2014) Rozbeh Jafari et al. Nature Protocols
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Arsenic Trioxide Reactivates Proteasome-Dependent Degradation of Mutant p53 Protein in Cancer Cells in Part via Enhanced Expression of Pirh2 E3 Ligase
- (2014) Wensheng Yan et al. PLoS One
- Targeting p53 for Novel Anticancer Therapy
- (2014) Zhen Wang et al. Translational Oncology
- A degradative detour for mutant TP53
- (2013) Helin Vakifahmetoglu-Norberg et al. Autophagy
- Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia
- (2013) M. Yanada et al. BLOOD
- Identification of potential synthetic lethal genes to p53 using a computational biology approach
- (2013) Xiaosheng Wang et al. BMC Medical Genomics
- Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells
- (2013) Ameya Paranjpe et al. CARCINOGENESIS
- Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro
- (2013) M. Burmakin et al. CLINICAL CANCER RESEARCH
- Chaperone-mediated autophagy degrades mutant p53
- (2013) H. Vakifahmetoglu-Norberg et al. GENES & DEVELOPMENT
- Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer
- (2013) Changhoon Yoo et al. INVESTIGATIONAL NEW DRUGS
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Small molecule induced reactivation of mutant p53 in cancer cells
- (2013) Xiangrui Liu et al. NUCLEIC ACIDS RESEARCH
- Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
- (2013) S Masciarelli et al. ONCOGENE
- Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells
- (2013) Hai-Bin Zhu et al. World Journal of Surgical Oncology
- Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53
- (2013) Christopher D. Wassman et al. Nature Communications
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- The substitutions G245C and G245D in the Zn2+-binding pocket of the p53 protein result in differences of conformational flexibility of the DNA-binding domain
- (2012) S.S. Pintus et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
- (2012) W Yan et al. ONCOGENE
- Synthetic lethality: exploiting the addiction of cancer to DNA repair
- (2011) M. Shaheen et al. BLOOD
- Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers
- (2011) Shouji Shimoyama CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
- (2011) Junli Liu et al. CELL
- Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs
- (2011) Rosa Puca et al. CELL CYCLE
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53
- (2011) R. Zandi et al. CLINICAL CANCER RESEARCH
- Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies
- (2011) F. R. Kona et al. CURRENT CANCER DRUG TARGETS
- Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function
- (2011) Ofer Margalit et al. INTERNATIONAL JOURNAL OF CANCER
- Mutant p53 Protein Is Targeted by Arsenic for Degradation and Plays a Role in Arsenic-mediated Growth Suppression
- (2011) Wensheng Yan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
- (2011) D. Li et al. MOLECULAR CANCER RESEARCH
- Arsenic Exposure and Toxicology: A Historical Perspective
- (2011) Michael F. Hughes et al. TOXICOLOGICAL SCIENCES
- HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression
- (2010) Jacqueline Kessler et al. BMC CANCER
- Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
- (2010) I Goldstein et al. CANCER GENE THERAPY
- USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
- (2010) Jian Yuan et al. CELL
- Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA
- (2010) Carolyn Y. Zhao et al. CELL CYCLE
- Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
- (2010) C. R. M. Lammens et al. Familial Cancer
- Cys-141 glutathionylation of human p53: Studies using specific polyclonal antibodies in cancer samples and cell lines
- (2010) Mohd. A. Yusuf et al. FREE RADICAL BIOLOGY AND MEDICINE
- SCH529074, a Small Molecule Activator of Mutant p53, Which Binds p53 DNA Binding Domain (DBD), Restores Growth-suppressive Function to Mutant p53 and Interrupts HDM2-mediated Ubiquitination of Wild Type p53
- (2010) Mark Demma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP
- (2010) Jia Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- RNA interference targeting mutant p53 inhibits growth and induces apoptosis in DU145 human prostate cancer cells
- (2010) HaiBin Zhu et al. MEDICAL ONCOLOGY
- Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides
- (2010) Célia Floquet et al. NUCLEIC ACIDS RESEARCH
- A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent
- (2009) Yali Kong et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Mutant p53 mediates survival of breast cancer cells
- (2009) L Y Lim et al. BRITISH JOURNAL OF CANCER
- Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis
- (2009) Vera V. Grinkevich et al. CANCER CELL
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- Cooperation of tumor-derived HBx mutants and p53-249ser mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line
- (2009) Weidong Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein
- (2009) Hyder INTERNATIONAL JOURNAL OF ONCOLOGY
- Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
- (2009) J M R Lambert et al. ONCOGENE
- A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
- (2009) S. Sur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Target identification using drug affinity responsive target stability (DARTS)
- (2009) B. Lomenick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- Structural Biology of the Tumor Suppressor p53
- (2008) Andreas C. Joerger et al. Annual Review of Biochemistry
- The mitochondrial p53 pathway
- (2008) Angelina V. Vaseva et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis
- (2008) L Weinmann et al. CELL DEATH AND DIFFERENTIATION
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
- (2008) T. Terzian et al. GENES & DEVELOPMENT
- Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells
- (2008) Hongyan Gu et al. MOLECULAR CANCER THERAPEUTICS
- Mutant p53 targeting by the low molecular weight compound STIMA-1
- (2008) Nicole Zache et al. Molecular Oncology
- Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
- (2008) J. E. Kravchenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
- (2008) F. M. Boeckler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now